About Biocydex
Biocydex is a company based in Poitiers (France) founded in 2006. Biocydex offers products and services including Vectisol, Long-V, and SD-70. Biocydex operates in a competitive market with competitors including Curapath, Flashpoint Therapeutics, Vim Meditech, Magle Group and DNA Nanobots, among others.
- Headquarter Poitiers, France
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biocydex
Biocydex offers a comprehensive portfolio of products and services, including Vectisol, Long-V, and SD-70.
Additive for preserving organs by limiting ischemia-reperfusion effects.
Sterile solution for rinsing and storing organs at controlled temperatures.
Aqueous liquid of Silver Sulfadiazine for topical antimicrobial applications.
Funding Insights of Biocydex
Detailed funding history for Biocydex
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biocydex
Investment portfolio details for Biocydex
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biocydex
Detailed financials for Biocydex
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biocydex Comparisons
Peer comparison for Biocydex
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biocydex
Biocydex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Curapath, Flashpoint Therapeutics, Vim Meditech, Magle Group and DNA Nanobots, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of drug delivery systems for therapeutic purposes
|
|
| Locked | Locked | Locked |
Flashpoint Therapeutics is developing nanotherapeutic candidates that can deliver precise RNA, DNA, and peptide payloads to specific cells at the right time.
|
|
| Locked | Locked | Locked |
Specializes in developing and manufacturing innovative parenteral drug delivery systems and sterile injectables.
|
|
| Locked | Locked | Locked |
Develops medical technologies for pharmaceuticals, therapeutics, and biopolymers.
|
|
| Locked | Locked | Locked |
Targeted chemotherapy, vaccines, and gene therapy are delivered via nanotechnology.
|
Detailed competitors of Biocydex
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biocydex
Complete news archive for Biocydex
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biocydex
Biocydex was founded in 2006.
Biocydex is headquartered in Poitiers, France. It is registered at Poitiers, Nouvelle-aquitaine, France.
Biocydex is a CRO providing RD services for preclinical drug discovery, drug delivery, formulation, and analytical method development to pharma clients. Apart from services, the company is also offering off-the-shelf products such as Vectisol and Long V tissue and organ preservation reagents for transplants, and Solvamax and Proteosol range of modified cyclodextrins for solubilization and stabilization of biological molecules.
Biocydex's top competitors include Flashpoint Therapeutics, Curapath and DNA Nanobots.
Biocydex offers Vectisol, Long-V, and SD-70.